NO20053459L - Nye forbindelser med selektiv inhiberende effekt av GSK3 - Google Patents
Nye forbindelser med selektiv inhiberende effekt av GSK3Info
- Publication number
- NO20053459L NO20053459L NO20053459A NO20053459A NO20053459L NO 20053459 L NO20053459 L NO 20053459L NO 20053459 A NO20053459 A NO 20053459A NO 20053459 A NO20053459 A NO 20053459A NO 20053459 L NO20053459 L NO 20053459L
- Authority
- NO
- Norway
- Prior art keywords
- gsk3
- inhibitory effect
- selective inhibitory
- compounds
- new compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203753A SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | New compounds |
PCT/SE2003/001957 WO2004055009A1 (en) | 2002-12-17 | 2003-12-15 | Novel compounds having selective inhibiting efect at gsk3 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20053459L true NO20053459L (no) | 2005-08-12 |
Family
ID=20289906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053459A NO20053459L (no) | 2002-12-17 | 2005-07-15 | Nye forbindelser med selektiv inhiberende effekt av GSK3 |
Country Status (23)
Country | Link |
---|---|
US (2) | US7595321B2 (es) |
EP (1) | EP1575942B1 (es) |
JP (1) | JP2006512337A (es) |
KR (1) | KR20050084362A (es) |
CN (1) | CN100360522C (es) |
AR (1) | AR042343A1 (es) |
AT (1) | ATE361291T1 (es) |
AU (1) | AU2003287137B2 (es) |
BR (1) | BR0317299A (es) |
CA (1) | CA2508045A1 (es) |
CY (1) | CY1106709T1 (es) |
DE (1) | DE60313658T2 (es) |
DK (1) | DK1575942T3 (es) |
ES (1) | ES2285221T3 (es) |
HK (1) | HK1080854A1 (es) |
MX (1) | MXPA05006244A (es) |
NO (1) | NO20053459L (es) |
NZ (1) | NZ540450A (es) |
PT (1) | PT1575942E (es) |
SE (1) | SE0203753D0 (es) |
TW (1) | TW200505905A (es) |
WO (1) | WO2004055009A1 (es) |
ZA (1) | ZA200504874B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704995B2 (en) | 2002-05-03 | 2010-04-27 | Exelixis, Inc. | Protein kinase modulators and methods of use |
SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203752D0 (sv) * | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
JP5756011B2 (ja) * | 2008-04-24 | 2015-07-29 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | グリコーゲン合成酵素キナーゼ3(gsk−3)としての1−(7−(ヘキサヒドロピロロ[3,4−c]ピロール−2(1h)−イル)キノリン−4−イル)−3−(ピラジン−2−イル)尿素誘導体とその関連化合物 |
WO2010141275A1 (en) * | 2009-06-01 | 2010-12-09 | Merck Sharp & Dohme Corp. | Pyrazine carboxamide orexin receptor antagonists |
BR112012017884A2 (pt) | 2010-01-19 | 2019-09-24 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, derivado de pirazina, métodos para o tratamento ou prevenção, para promoção óssea, e, para tratar lesões ósseas em cânceres |
TWI806385B (zh) | 2016-07-20 | 2023-06-21 | 瑞士商諾華公司 | 胺基吡啶衍生物及其作為選擇性alk-2抑制劑之用途 |
CN115038443A (zh) | 2019-11-22 | 2022-09-09 | 因西特公司 | 包含alk2抑制剂和jak2抑制剂的组合疗法 |
IL298767A (en) | 2020-06-16 | 2023-02-01 | Incyte Corp | ALK2 inhibitors for the treatment of anemia |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5472823A (en) | 1992-01-20 | 1995-12-05 | Hitachi Chemical Co., Ltd. | Photosensitive resin composition |
JPH10152622A (ja) | 1996-11-26 | 1998-06-09 | Dainippon Ink & Chem Inc | ジスアゾ化合物およびジスアゾ顔料 |
MA26473A1 (fr) | 1997-03-01 | 2004-12-20 | Glaxo Group Ltd | Composes pharmacologiquement actifs. |
BR0108363A (pt) * | 2000-02-16 | 2004-02-10 | Neurogen Corp | Composto, métodos para modular função de receptor de crf e acoplado a proteìna g, para tratar um distúrbio ou doença do snc, para localizar receptores de crf em amostras de seção de tecidos, para inibir a ligação de crf a um receptor de crf¹ e para alterar a atividade de transdução de sinal de um receptor de crf¹ e composição farmacêutica |
EE04877B1 (et) * | 2000-03-07 | 2007-08-15 | Aventis Pharma Deutschland Gmbh | Asendatud 3-fenl-5-alkoks-1,3,4-oksadiasol-2-oon, selle valmistamine ja kasutamine hormoontundlikku lipaasi prssivas ravimis ning seda sisaldav suhkurt?ve ravim |
AR029489A1 (es) * | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
KR20090092832A (ko) | 2001-05-11 | 2009-09-01 | 바이오비트럼 에이비(피유비엘) | 비만, 제 ⅱ 형 당뇨병 및 cns 장애의 치료를 위한 신규한 아릴술폰아미드 화합물 |
CA2484209C (en) * | 2002-05-03 | 2013-06-11 | Exelixis, Inc. | Protein kinase modulators and methods of use |
SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203752D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203754D0 (sv) * | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
-
2002
- 2002-12-17 SE SE0203753A patent/SE0203753D0/xx unknown
-
2003
- 2003-12-04 TW TW092134210A patent/TW200505905A/zh unknown
- 2003-12-09 AR ARP030104528A patent/AR042343A1/es unknown
- 2003-12-15 BR BR0317299-6A patent/BR0317299A/pt not_active IP Right Cessation
- 2003-12-15 ES ES03781206T patent/ES2285221T3/es not_active Expired - Lifetime
- 2003-12-15 KR KR1020057011135A patent/KR20050084362A/ko not_active Application Discontinuation
- 2003-12-15 MX MXPA05006244A patent/MXPA05006244A/es active IP Right Grant
- 2003-12-15 EP EP03781206A patent/EP1575942B1/en not_active Expired - Lifetime
- 2003-12-15 DE DE60313658T patent/DE60313658T2/de not_active Expired - Lifetime
- 2003-12-15 PT PT03781206T patent/PT1575942E/pt unknown
- 2003-12-15 CA CA002508045A patent/CA2508045A1/en not_active Abandoned
- 2003-12-15 AU AU2003287137A patent/AU2003287137B2/en not_active Ceased
- 2003-12-15 DK DK03781206T patent/DK1575942T3/da active
- 2003-12-15 CN CNB2003801064833A patent/CN100360522C/zh not_active Expired - Fee Related
- 2003-12-15 JP JP2004560225A patent/JP2006512337A/ja active Pending
- 2003-12-15 AT AT03781206T patent/ATE361291T1/de not_active IP Right Cessation
- 2003-12-15 WO PCT/SE2003/001957 patent/WO2004055009A1/en active IP Right Grant
- 2003-12-15 US US10/539,545 patent/US7595321B2/en not_active Expired - Fee Related
- 2003-12-15 NZ NZ540450A patent/NZ540450A/en unknown
-
2005
- 2005-06-14 ZA ZA200504874A patent/ZA200504874B/en unknown
- 2005-07-15 NO NO20053459A patent/NO20053459L/no not_active Application Discontinuation
-
2006
- 2006-01-18 HK HK06100841A patent/HK1080854A1/xx not_active IP Right Cessation
-
2007
- 2007-07-04 CY CY20071100890T patent/CY1106709T1/el unknown
-
2009
- 2009-09-28 US US12/568,266 patent/US20100087396A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR042343A1 (es) | 2005-06-15 |
AU2003287137A1 (en) | 2004-07-09 |
BR0317299A (pt) | 2005-11-08 |
CY1106709T1 (el) | 2012-05-23 |
EP1575942A1 (en) | 2005-09-21 |
KR20050084362A (ko) | 2005-08-26 |
EP1575942B1 (en) | 2007-05-02 |
AU2003287137B2 (en) | 2007-07-05 |
ATE361291T1 (de) | 2007-05-15 |
US7595321B2 (en) | 2009-09-29 |
SE0203753D0 (sv) | 2002-12-17 |
MXPA05006244A (es) | 2005-08-19 |
NZ540450A (en) | 2007-10-26 |
WO2004055009A1 (en) | 2004-07-01 |
CA2508045A1 (en) | 2004-07-01 |
CN1726210A (zh) | 2006-01-25 |
WO2004055009A8 (en) | 2005-06-30 |
DE60313658D1 (de) | 2007-06-14 |
DE60313658T2 (de) | 2008-01-10 |
ES2285221T3 (es) | 2007-11-16 |
ZA200504874B (en) | 2006-04-26 |
US20100087396A1 (en) | 2010-04-08 |
US20060116385A1 (en) | 2006-06-01 |
TW200505905A (en) | 2005-02-16 |
HK1080854A1 (en) | 2006-05-04 |
DK1575942T3 (da) | 2007-09-03 |
PT1575942E (pt) | 2007-07-09 |
CN100360522C (zh) | 2008-01-09 |
JP2006512337A (ja) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053459L (no) | Nye forbindelser med selektiv inhiberende effekt av GSK3 | |
NO20053460L (no) | Nye forbindelser med selektiv inhibiterende effekt ved GSK3 | |
ES2395704T3 (es) | Derivados de isoxazolina y su uso como pesticida | |
NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
NO20060972L (no) | Pyridylderivater og deres anvendelse som terapeutiske midler | |
NO20051965L (no) | Nye piperidinderivater for anvendelse ved behandling av kemokinmedierte sykdomstilstander. | |
NO20062942L (no) | Fremgangsmate for fremstilling av en fast, oralt anvendelig farmasoytisk sammensetning | |
NO20061107L (no) | CRF-antagonister og heterobrcykliske forbindelser | |
CA2568356A1 (en) | Bicyclic heterocycles as hiv integrase inhibitors | |
NO20001100L (no) | IL-8 reseptorantagonister | |
NO20061126L (no) | Aminopyroner og deres anvendelse som ATM-inhibitorer | |
NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
EA200300333A1 (ru) | Новые тиадиазолы и оксадиазолы и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
RU2008129723A (ru) | Ингибиторы ccr9 активности | |
NO20060383L (no) | Substituerte diketopiperaziner og deres anvendelse som oksytocinantagonister | |
EA200600490A1 (ru) | Новые сульфонамиды в качестве средств защиты растений | |
JP2005537323A5 (es) | ||
NO20051089L (no) | Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer | |
RU2009102270A (ru) | Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы | |
HUP0003039A2 (hu) | Szinergetikus fungicid hatóanyagkeverék és alkalmazása | |
ES2139246T3 (es) | Derivados de n-(benciloxi sustituido en orto)imina y su uso como fungicidas, acaricidas o insecticidas. | |
NO20074346L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20030509D0 (no) | Nye N-(2-fenyl-3-aminopropyl)naftamider | |
NO995007L (no) | Forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |